LBRY Block Explorer

LBRY Claims • muvalaplin-world-first-drug-to-target

527c073164a8e65e82d3a730ff4a534009a337b0

Published By
Created On
29 Aug 2023 09:50:00 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
Muvalaplin- World first drug to target previously untreatable life-threatening ‘bad cholesterol’
A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke.

High levels of Lipoprotein(a), known as Lp(a), impact one in five people globally with no approved treatment currently on the market.

The trial demonstrated the success of Muvalaplin - the first oral drug ever developed to target Lp(a) - effectively lowering levels by up to 65%. It works by disrupting the ability for Lp(a) to form in the body.

Research Paper: Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation https://jamanetwork.com/journals/jama/fullarticle/2808864

News Source: https://www.eurekalert.org/news-releases/999728

Emerging Technologies eBook https://www.blog.qualitypointtech.com/p/emerging-technologies-for-profit-guide.html

Join this channel to get access to perks:
https://www.youtube.com/channel/UCYl4FEoRuAv9G2v0cid5VnA/join

Opportunity to convert Your Idea into Online Business https://www.blog.qualitypointtech.com/2023/05/opportunity-to-convert-your-idea-into.html
...
https://www.youtube.com/watch?v=oX8otzrMD5A
Author
Content Type
Unspecified
video/mp4
Language
English
Open in LBRY

More from the publisher

Controlling
VIDEO
INTER
Controlling
VIDEO
HYPER
Controlling
VIDEO
ENGIN
Controlling
VIDEO
FULL
Controlling
VIDEO
SCIEN
Controlling
VIDEO
PIG K
Controlling
VIDEO
A PER
Controlling
VIDEO
SICK
Controlling
VIDEO
AI-DE